Bibliographic Details
| Title: |
Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19. |
| Authors: |
Reyno, L., Seymour, L., Tu, D., Dent, S., Gelmon, K., Walley, B., Pluzanska, A., Gorbunova, V., Garin, A., Jassem, J., Pienkowski, T., Dancey, J., Pearce, L., MacNeil, M., Marlin, S., Lebwohl, D., Voi, M., Pritchard, K., Marx, Gavin M.1, Rutovitz, Josie J.1 |
| Source: |
Women's Oncology Review. Jun2004, Vol. 4 Issue 2, p133-134. 2p. |
| Database: |
Academic Search Ultimate |
